RAPT Therapeutics, Inc. (RAPT)

RAPT Therapeutics Statistics

Total Valuation

RAPT has a market cap or net worth of $1.79 billion. The enterprise value is $1.63 billion.

Market Cap	1.79B
Enterprise Value	1.63B

Important Dates

The next estimated earnings date is Thursday, March 5, 2026, before market open.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

RAPT has 30.92 million shares outstanding. The number of shares has increased by 347.95% in one year.

Current Share Class	30.92M
Shares Outstanding	30.92M
Shares Change (YoY)	+347.95%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	0.23%
Owned by Institutions (%)	35.20%
Float	23.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.40
P/TBV Ratio	11.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.04, with a Debt / Equity ratio of 0.02.

Current Ratio	12.04
Quick Ratio	11.76
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -85.37% and return on invested capital (ROIC) is -55.17%.

Return on Equity (ROE)	-85.37%
Return on Assets (ROA)	-51.35%
Return on Invested Capital (ROIC)	-55.17%
Return on Capital Employed (ROCE)	-73.93%
Weighted Average Cost of Capital (WACC)	6.95%
Revenue Per Employee	n/a
Profits Per Employee	-$1.76M
Employee Count	60
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +522.20% in the last 52 weeks. The beta is 0.49, so RAPT's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	+522.20%
50-Day Moving Average	41.50
200-Day Moving Average	22.27
Relative Strength Index (RSI)	79.63
Average Volume (20 Days)	4,862,196

Short Selling Information

The latest short interest is 1.78 million, so 5.75% of the outstanding shares have been sold short.

Short Interest	1.78M
Short Previous Month	1.65M
Short % of Shares Out	5.75%
Short % of Float	7.73%
Short Ratio (days to cover)	4.90

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-112.64M
Pretax Income	-105.64M
Net Income	-105.64M
EBITDA	-111.66M
EBIT	-112.64M
Earnings Per Share (EPS)	-$4.88

Balance Sheet

The company has $157.34 million in cash and $2.60 million in debt, with a net cash position of $154.75 million or $5.00 per share.

Cash & Cash Equivalents	157.34M
Total Debt	2.60M
Net Cash	154.75M
Net Cash Per Share	$5.00
Equity (Book Value)	151.98M
Book Value Per Share	9.02
Working Capital	147.67M

Cash Flow

In the last 12 months, operating cash flow was -$86.58 million and capital expenditures -$84,000, giving a free cash flow of -$86.66 million.

Operating Cash Flow	-86.58M
Capital Expenditures	-84,000
Free Cash Flow	-86.66M
FCF Per Share	-$2.80

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RAPT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-347.95%
Shareholder Yield	-347.95%
Earnings Yield	-5.92%
FCF Yield	-4.85%

Analyst Forecast

The average price target for RAPT is $56.22, which is -2.63% lower than the current price. The consensus rating is "Buy".

Price Target	$56.22
Price Target Difference	-2.63%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-17.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 17, 2025. It was a reverse split with a ratio of 1:8.

Last Split Date	Jun 17, 2025
Split Type	Reverse
Split Ratio	1:8

Scores

Altman Z-Score	n/a
Piotroski F-Score	2